Vallente, Archie D.

HRN: 27-90-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/06/2025
10/13/2025
IV DRIP
40mg
Q24h
PSNB(ER Delivery)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: